Smruti K. Patel · Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Follow
Article1 min read·Published Nov 2026

Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Nov 2026 · 1 min read

In brief

In brief

This study examines genomic profiles of 93 chondrosarcoma patients, comparing IDH-mutant versus IDH wild-type tumors and identifying TP53 mutations as a prognostic marker for worse clinical outcomes. The research advances molecular understanding of the most common primary bone malignancy in adults.

Written by the GCMD Library team from the article.

Smruti K. Patel

Chondrosarcomas are the most common primary bone tumor in adults. Isocitrate dehydrogenase 1 (IDH1) and IDH2 mutations are prevalent. We aimed to assess the clinico-genomic properties of IDH mutant versus IDH wild-type (WT) chondrosarcomas as well as alterations in other genes. We included 93 patients with conventional and dedifferentiated chondrosarcoma for which there were available clinical nex…

Statements in this article

  1. Chondrosarcomas are the most common primary bone tumor in adults.

    Established
  2. IDH1 and IDH2 mutations are prevalent in chondrosarcomas.

    Established

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.